NCT02137824 A Modified Sinus Floor Elevation Technique - a Pilot Study on 12 Patients
| NCT ID | NCT02137824 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medical University of Vienna |
| Condition | Maxillary Sinus |
| Study Type | INTERVENTIONAL |
| Enrollment | 12 participants |
| Start Date | 2014-05 |
| Primary Completion | 2030-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 12 participants in total. It began in 2014-05 with a primary completion date of 2030-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of the present study is to establish a modified minimally invasive surgical technique for sinus floor augmentation with a residual bone height of 3-6mm. Hypothesis: The investigators expect that the present surgical technique allows to achieve an adequate implant bed of at least 10mm height after a healing period of 3-5 months. Further the modification of the technique enables a reduced patient stress level.
Eligibility Criteria
Inclusion Criteria: * residual bone height of 3-6mm * residual bone width of \>4mm Exclusion Criteria: * not treated periodontal disease * smoker (\>5cig/day) * acute or chronic sinusitis
Contact & Investigator
Kristina Bertl, PD, DMD, MSc
✉ kristina.bertl@meduniwien.ac.atFrequently Asked Questions
Who can join the NCT02137824 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Maxillary Sinus. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02137824 currently recruiting?
Yes, NCT02137824 is actively recruiting participants. Contact the research team at kristina.bertl@meduniwien.ac.at for enrollment information.
Where is the NCT02137824 trial being conducted?
This trial is being conducted at Vienna, Austria.
Who is sponsoring the NCT02137824 clinical trial?
NCT02137824 is sponsored by Medical University of Vienna. The trial plans to enroll 12 participants.